DNAtrix Employee Directory
Biotechnology ResearchCalifornia, United States2-10 Employees
DNAtrix is a privately held biotechnology company developing therapies that use virus-driven mechanisms to treat cancer. Its approach centers on an engineered adenovirus intended to selectively infect and kill cancer cells while minimizing harm to healthy tissue. The company’s lead candidate, DNX-2401, is advancing toward a global pivotal Phase 3 trial for recurrent glioblastoma and is also being evaluated in a Phase 1 study for diffuse intrinsic pontine glioma, which has FDA Fast Track and Rare Pediatric Disease designations. A second candidate, DNX-2440, is in Phase 1 trials for colorectal cancer with liver metastasis. Based in San Diego, California, DNAtrix operates with a small team focused on developing virus-based immunotherapies. It sits within the biotechnology research sector, pursuing cancer treatments that leverage viral mechanisms to engage the immune system against tumors.